A week of pharmaceutical innovation for MB Therapeutics
MB Therapeutics took part in two major events where pharmaceutical innovation was at the heart of the discussions: the 3D PharmaPrint Healthcare Symposium in Rotterdam and l’A3P Product Life Cycle in Lyon. These events provided an opportunity to share ideas, explore the latest innovations, and discuss the upcoming challenges in the pharmaceutical industry.
3D PharmaPrint Healthcare Symposium – Rotterdam
The 3D PharmaPrint Healthcare Symposium, held in Rotterdam, brought together industry experts to discuss the impact of 3D pharmaceutical printing on the healthcare sector. This technology offers innovative possibilities, particularly for personalizing medications and manufacturing custom-made pharmaceutical forms.
At MB Therapeutics, we firmly believe that 3D printing is the key to transforming how medications are designed and manufactured. Through this technology, we can create treatments tailored to each patient’s specific needs, enabling us to offer more precise and effective medicine. This symposium reinforced the central role of 3D printing in the future of pharmacie.
A3P Product Life Cycle – Lyon
In Lyon, the A3P Product Life Cycle provided a unique platform for pharmaceutical professionals to engage in key discussions. The event highlighted crucial topics for the future of the industry, such as control strategy, manufacturing process management, QbD (Quality by Design), an essential guide for optimizing pharmaceutical processes.
As a member of the GIC (“Groupe d’Intérêt Commun”) of l’A3P, Damien Stefanelli, COO of MB Therapeutics, had the opportunity to share his expertise on these critical issues. Active participation in these strategic discussions allows MB Therapeutics to remain at the forefront of regulatory developments and ensure that our personalized drug manufacturing solutions comply with the strictest standards.
This event also emphasized the importance of mastering processes within the pharmaceutical industry to guarantee the quality, safety, and efficacy of treatments.
MB Therapeutics : At the heart of pharmaceutical innovation
These events reinforce our commitment to delivering innovative and effective solutions for the pharmaceutical industry of tomorrow. With our expertise and vision, MB Therapeutics is ready to play a major role in this transformation.
